Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0DJ9D
|
|||
| Drug Name |
Burosumab
|
|||
| Synonyms |
Burosumab [USAN]; UNII-G9WJT6RD29; G9WJT6RD29
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | X-linked hypophosphataemia [ICD-11: 5C63.22] | Approved | [1] | |
| Company |
Ultragenyx Pharmaceutical/Kyowa Hakko Kirin
|
|||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fibroblast growth factor-23 (FGF23) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.